HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/26/2012 -- PSS World Medical (NasdaqNM:PSSI) are trading at $28.57 and is +25.69% from its 50-day Moving Average price of $22.7314 and +30.99% from its 200-day Moving Average price of $21.8105. The average trading volume is 1548930 shares and its market capitalization is $1.414B. Major health-care services and technology company McKesson (NYSE: MCK ) announced on Thursday that it plans to acquire PSS World Medical (Nasdaq: PSSI ) for $2.1 billion. PSS World Medical supplies medical products to front-line caregivers in the U.S. Both company's boards of directors approved the buyout. However, regulatory clearance, and approval by PSS World Medical's shareholders, is still pending. Assuming these approvals go as planned, PSS World Medical will combine with McKesson's Medical Surgical unit. The combined company will roll up to McKesson's Distribution Solutions segment.
How Should Investors React To PSSI Now? Find Out Here
GSI Technology, I (NasdaqNM:GSIT) are trading at $5.73 and is +18.21% from its 50-day Moving Average price of $4.8472 and +24.29% from its 200-day Moving Average price of $4.6101. The average trading volume is 33231 shares and its market capitalization is $155.9M. GSI Technology, Inc. (Nasdaq: GSIT) reported net income of $1.1 million, or $0.04 per diluted share, on net revenues of $16.0 million for its second fiscal quarter ended September 30, 2012, compared to net income of $1.7 million, or $0.06 per diluted share, on net revenues of $20.8 million in the comparable period a year ago. In the prior quarter ended June 30, 2012, the Company earned $920,000, or $0.03 per diluted share, on net revenues of $16.8 million. For the six months ended September 30, 2012, net income was $2.1 million, or $0.07 per diluted share, on net revenues of $32.8 million, compared to net income of $4.9 million, or $0.16 per diluted share, on net revenues of $43.8 million in the first six months of fiscal 2012. Gross margin was 42.6% compared to 43.9% in the comparable period of fiscal 2012.
Can GSIT Continue To Move Higher? Find Out Here
Gardner Denver, I (NYSE:GDI) reported EPS of 5.52. For the Current Fiscal year, the company is expected to report EPS of 5.38. For the Next Quarter and Next Year, the company is expected to report EPS of 1.25 and 5.30 respectively. At Current Market Price, GDI is in distance of +9.90% from its 50-day Moving Average price of $60.0533 and +14.26% from its 200-day Moving Average price of $57.7611. Gardner Denver, Inc. ( NYSE : GDI ) confirmed that its Board of Directors, working together with its management team and the Company's financial advisor, Goldman, Sachs & Co., are exploring strategic alternatives to enhance shareholder value. These alternatives could include, among other things, enhancing the Company's existing strategic plan or a possible sale or merger of the Company. The Company stated that no decision has been made and that there can be no assurance that the Board's exploration of strategic alternatives will result in any transaction being entered into or consummated. Gardner Denver does not intend to discuss or disclose developments with respect to this process until the Board has approved a definitive course of action.
Can GDI Touch $85.00 From Here: Get A Free Analyst Report
Shares of rapid production company Proto Labs (NYSE:PRLB) jumped 20% today after reporting earnings. Third-quarter revenue jumped 21% from a year ago to $32.5 million, and net income rose 22% to $6.7 million. Revenue beat estimates and adjusted earnings per share of $0.29 were $0.06 ahead of estimates. Proto Labs continues to benefit from the need for faster and faster production of parts, and the operational momentum doesn't appear to be slowing at all. But the stock is currently trading at 30 times next year's earnings, a steep price even for a company that is growing. I'll sit out this move just based on valuation, but if the pop subsides, the stock may be worth another look. Proto Labs, Inc. (NYSE:PRLB) are trading at $35.96 and is +11.99% from its 50-day Moving Average price of $32.1103 and +8.22% from its 200-day Moving Average price of $33.2284. The average trading volume is 184918 shares and its market capitalization is $860.7M.
Can PRLB Continue Its Rally? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)